<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT05062252</url>
  </required_header>
  <id_info>
    <org_study_id>P06.003.01</org_study_id>
    <nct_id>NCT05062252</nct_id>
  </id_info>
  <brief_title>Mirror Medacta Shoulder System Pivotal Trial</brief_title>
  <official_title>Multicentric, Prospective, Comparative Trial to Assess the Efficacy and Safety of an Anatomic Total Shoulder System.</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Medacta International SA</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Medacta International SA</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to demonstrate safety and efficacy of the Mirror Medacta&#xD;
      Shoulder System in total shoulder arthroplasty.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Not yet recruiting</overall_status>
  <start_date type="Anticipated">September 30, 2021</start_date>
  <completion_date type="Anticipated">September 30, 2025</completion_date>
  <primary_completion_date type="Anticipated">September 30, 2024</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Non-Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Oxford Shoulder Score</measure>
    <time_frame>12 months</time_frame>
    <description>0 (worst) - 48 (best)</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Device Success Rate</measure>
    <time_frame>24 months</time_frame>
    <description>Kaplan Meier survival curve, examining the following end-points:&#xD;
component revision for any reason;&#xD;
aseptic loosening;&#xD;
any definite change in the position of components.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Oxford Shoulder Score</measure>
    <time_frame>24 months</time_frame>
    <description>0 (worst) - 48 (best)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Constant score</measure>
    <time_frame>24 months</time_frame>
    <description>0(worst) - 100 (best)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Subjective Shoulder Value</measure>
    <time_frame>24 months</time_frame>
    <description>0(worst) - 100 (best)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Device parameters</measure>
    <time_frame>24 months</time_frame>
    <description>Devices will be assessed to determine percentage of participants that demonstrated the following after total shoulder arthroplasty:&#xD;
Radiolucencies,&#xD;
Migration,&#xD;
Osteolysis,&#xD;
Subsidence</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">100</enrollment>
  <condition>Arthritis Shoulder</condition>
  <condition>Post-traumatic Arthrosis of Other Joints, Upper Arm</condition>
  <arm_group>
    <arm_group_label>Mirror group</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Mirror Medacta Shoulder System</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Historical Control group</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Total shoulder arthroplasty system</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Mirror Medacta Shoulder System</intervention_name>
    <description>Anatomic total shoulder arthroplasty system</description>
    <arm_group_label>Mirror group</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Medacta Shoulder System</intervention_name>
    <description>Anatomic total shoulder arthroplasty system - standard configuration</description>
    <arm_group_label>Historical Control group</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Age â‰¥ 18 yr&#xD;
&#xD;
          -  Clinical indication for anatomic primary total shoulder replacement due to&#xD;
             osteoarthritis and/or posttraumatic arthritis&#xD;
&#xD;
          -  Willingness and ability to comply with study protocol&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Medical condition or balance impairment that could lead to falls&#xD;
&#xD;
          -  Prior rotator cuff surgery&#xD;
&#xD;
          -  Cuff tear arthropathy/insufficient rotator cuff&#xD;
&#xD;
          -  Insufficient bone quality which may affect the stability of the implant&#xD;
&#xD;
          -  Neuromuscular compromise of shoulder or other disabilities affecting the maximum&#xD;
             functional outcomes&#xD;
&#xD;
          -  Weight bearing shoulder due to wheel chair, crutches, rollator at the time of&#xD;
             operation&#xD;
&#xD;
          -  Active metastatic or neoplastic disease at the shoulder joint&#xD;
&#xD;
          -  Chemotherapy treatment/radiotherapy within 6 mo before surgery&#xD;
&#xD;
          -  &gt;5 mg/day of corticosteroids, excluding inhalers, within 3 years before surgery&#xD;
&#xD;
          -  Pregnancy or plan to become pregnant during study period&#xD;
&#xD;
          -  Inability to understand study or a history of noncompliance with medical advice&#xD;
&#xD;
          -  Alcohol or drug abuse&#xD;
&#xD;
          -  Current enrollment in any clinical research study that might interfere with this study&#xD;
&#xD;
          -  Metal allergies or sensitivity.&#xD;
&#xD;
          -  Previous or current infection at or near the site of implantation.&#xD;
&#xD;
          -  Current distant or systemic infection&#xD;
&#xD;
          -  Patient, whose infomed consent form should be taken in an emergency situation&#xD;
&#xD;
          -  ONLY for women of childbearing age: a positive pregnancy test (urine / blood)&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Matthias A Zumstein, Prof Dr. med</last_name>
    <role>Principal Investigator</role>
    <affiliation>Lindenhofgruppe AG (Bern)</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Mara Colombo</last_name>
    <phone>+41 091 6966060</phone>
    <email>colombo@medacta.ch</email>
  </overall_contact>
  <verification_date>September 2021</verification_date>
  <study_first_submitted>September 21, 2021</study_first_submitted>
  <study_first_submitted_qc>September 21, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">September 30, 2021</study_first_posted>
  <last_update_submitted>September 21, 2021</last_update_submitted>
  <last_update_submitted_qc>September 21, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">September 30, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Osteoarthritis</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

